Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Ghosts of GSK’s billion dollar mistake return; New date for electronic submissions of DMFs
This week, Phispers tells us why David Hung’s taking charge as CEO of Axovant could signal the